Method of treating cancer by administering CSF-1R antibodies and a TLR9 agonist

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9192667
APP PUB NO 20140314771A1
SERIAL NO

14257480

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to the combination therapy of antibodies against human CSF-1R with a TLR9 agonist.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • HOFFMANN-LA ROCHE INC.

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Hoves, Sabine Habach, DE 17 183
Ries, Carola Penzberg, DE 35 748
Ruettinger, Dominik Seehausen, DE 10 144
Wartha, Katharina Munich, DE 12 249

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 May 24, 2027
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00